Astrana Health (ASTH) FY2021 results: revenue $774 million, up 12.6% on the year
Astrana Health, Inc. (ASTH) reported revenue of $774 million for fiscal 2021, the year ended 31 December 2021, up 12.6% on the year before. Net income was $69 million, up 82.9%, and diluted earnings per share $1.52. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2022.
Revenue
$774 million
+12.6% on the year
FY2016FY2021
Operating margin
12.7%
11.7% a year earlier
FY2016FY2021
Net income
$69 million
+82.9% on the year
FY2016FY2021
Diluted EPS
$1.52
+50.5% on the year
FY2016FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
70.3
46.2
13.7
+52.4%
Capital expenditure
19.2
1.2
1.0
+1,551.5%
Free cash flow
51.1
45.0
12.6
+13.6%
Free cash flow margin
6.6%
6.5%
2.3%
Cash from investing
16.5
95.5
-181
-82.7%
Cash from financing
-47.7
-51.7
163
Depreciation and amortisation
17.5
18.4
18.3
-4.5%
Share-based compensation
6.7
3.4
1.5
+99.4%
Buybacks
5.7
0.5
7.6
+968.7%
Dividends paid
31.1
51.3
61.7
-39.4%
Diluted shares, weighted
45m
37m
36m
+21.2%
Shares outstanding at period end
45m
42m
36m
+5.6%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
448
331
192
+35.5%
Non-controlling interest
5.9
0.1
0.8
+6,727.6%
Redeemable equity
56.5
114
169
-50.2%
Debt
184
241
242
-23.8%
Operating lease liabilities
13.2
15.9
11.4
-16.8%
Finance lease liabilities
1.0
0.3
0.4
+212.9%
Other liabilities
159
116
114
+37.3%
Total liabilities and equity
867
817
729
+6.1%
Goodwill
246
232
239
+6.0%
Intangible assets
82.8
87.0
103
-4.8%
Investments
53.4
67.7
117
-21.1%
Cash and equivalents
233
193
103
+20.5%
Receivables
10.6
7.1
11.0
+50.3%
Other assets
241
230
156
+4.9%
Total assets
867
817
729
+6.1%
10-K for the year ended 31 December 2021, filed 28 February 2022: the filing.